chr7-6005918-C-G
Variant summary
The NM_000535.7(PMS2):c.137G>C (p.Ser46Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The gene PMS2 is a cancer driver gene (CancerMine: 1 driver citations). The variant is absent from the gnomAD population database at sites with sufficient sequencing coverage. In-silico predictor (REVEL) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. The affected nucleotide is highly conserved across species (PhyloP 100-way vertebrate score: 7.54). No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. A different missense at the same amino acid position has been reported as Pathogenic/Likely Pathogenic in ClinVar: p.S46N: Pathogenic/Likely_pathogenic (ClinVar VariationId 91301, 2 stars) Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.S46G: Uncertain_significance (ClinVar VariationId 525851, 1 star); p.S46R: Uncertain_significance (ClinVar VariationId 1771527, 1 star); p.S46= (synonymous): Likely_benign (ClinVar VariationId 1771525, 1 star)
Frequency
Consequence
NM_000535.7 missense
Scores
Clinical Significance
Conservation
Publications
- Lynch syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- Lynch syndrome 4Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp
- mismatch repair cancer syndrome 1Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- mismatch repair cancer syndrome 4Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- malignant pancreatic neoplasmInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- ovarian cancerInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- Muir-Torre syndromeInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- rhabdomyosarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- breast cancerInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- prostate cancerInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- hereditary breast carcinomaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
Classification according to ACGS-UK Somatic Oncogenicity v2025
Our verdict: Uncertain_significance. The variant received 3 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| O3Absent or very rare in population | Absent or extremely rare in gnomAD (AC ≤ 2) — O3 moderate; GnomAD: AF = absent, AC = 0 — absent/extremely rare (O3 moderate [+2]) | ||
| O6Computational evidence supports deleterious effect | Computational evidence supports a deleterious/oncogenic effect; Missense variant — primary computational scorer supports an oncogenic/deleterious effect |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_000535.7. You can select a different transcript below to see updated classification assignments.
RefSeq Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
PMS2 | MANE Select | c.137G>C p.Ser46Thr | missense | Exon 2 of 15 | Prot: NP_000526.2 UniProt: | |
PMS2 | c.323G>C p.Ser108Thr | missense | Exon 3 of 16 | Prot: NP_001393795.1 UniProt: | ||
PMS2 | c.137G>C p.Ser46Thr | missense | Exon 2 of 15 | Prot: NP_001308943.1 UniProt: |
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
PMS2 | TSL:1MANE Select | c.137G>C p.Ser46Thr | missense | Exon 2 of 15 | Prot: ENSP00000265849.7 UniProt: | |
PMS2 | TSL:1 | c.137G>C p.Ser46Thr | missense | Exon 2 of 11 | Prot: ENSP00000371758.4 UniProt: | |
PMS2 | TSL:1 | n.137G>C | non_coding_transcript_exon | Exon 2 of 13 | Prot: ENSP00000514464.1 UniProt: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 3 sources | |||||
GnomAD3 genomes | Cov:33 | ||||
GnomAD4 exome | Cov:31 | ||||
GnomAD4 genome | Cov:33 | ||||
ClinVar
Not reported inComputational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Pathogenic | 26 | |
AlphaMissense | Pathogenic | 0.61 | |
BayesDel_addAF | Pathogenic | 0.43 | D |
BayesDel_noAF | Pathogenic | 0.38 | |
CADD | Pathogenic | 28 | |
DANN | Uncertain | 1.0 | |
DEOGEN2 | Uncertain | 0.79 | D |
Eigen | Pathogenic | 1.1 | |
Eigen_PC | Pathogenic | 0.98 | |
FATHMM_MKL | Pathogenic | 0.99 | D |
FuncVEP CTI | Pathogenic | 0.91 | |
GPN-Star LLR | N/A | -5.8 | |
GPN-Star score | N/A | 5.8 | |
LIST_S2 | Pathogenic | 0.98 | D |
M_CAP | Uncertain | 0.21 | D |
MetaRNN | Pathogenic | 0.96 | D |
MetaSVM | Pathogenic | 0.88 | D |
Mutation Taster | N/A | 4/96 | disease causing |
MutationAssessor | Pathogenic | 4.3 | H |
PhyloP100 | Pathogenic | 7.5 | |
popEVE | Benign | -4.1 | |
PrimateAI | Uncertain | 0.65 | T |
PROVEAN | Uncertain | -2.6 | D |
REVEL | Pathogenic | 0.87 | |
Sift | Uncertain | 0.0060 | D |
Sift4G | Uncertain | 0.0050 | D |
Varity_R | N/A | 0.96 | |
VESM-3B | Benign | -11 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Benign | 0.0 | |
SpliceAI score (max) | Benign | 0.0 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.